Abraxane and haemoglobin decreased 
Abraxane and haemoglobin decreased Patient Reports February 11, 2012
Abraxane Side Effects Report #5920899-7
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 15, 2008. Female patient, weighting 141.0 lb, was diagnosed with ovarian cancer recurrent and was treated with Abraxane. After drug was administered, patient experienced the following side effects: condition aggravated, haematocrit decreased, haemoglobin decreased, vaginal haemorrhage, white blood cell count decreased. Abraxane dosage: 260 MG/ M2 ONCE EVERY 21 DAYS IV. During the same period patient was treated with VANDETANIB. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5788568-4
Abraxane side effect was reported by a Health Professional from UNITED STATES on June 25, 2008. Male patient, 75 years of age, weighting 168.2 lb, was diagnosed with non-small cell lung cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: body temperature increased, cough, dyspnoea, haemoglobin decreased, malaise, orthostatic hypotension, oxygen saturation decreased. Abraxane dosage: 78MG QWK IVPB. During the same period patient was treated with CARBOPLATIN, ALLOPURINOL, ASPIRIN, DIGOXIN, LOPRESSOR, ULTRAM, ZOCOR, LEXAPRO. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5084304-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 01, 2006. Male patient, 68 years of age, weighting 198.0 lb, was diagnosed with non-small cell lung cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: aptyalism, constipation
, decreased appetite, febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypokalaemia, hypomagnesaemia, platelet count decreased. Abraxane dosage: 2 DOSES (600 MG) INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #6105670-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2009. Female patient, weighting 121.3 lb, was diagnosed with neoplasm malignant and was treated with Abraxane. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pulmonary embolism
. Abraxane dosage: 410 MG D1/CYCLE 042. During the same period patient was treated with VANDETANIB, PANCRELIPASE, ATENOLOL, ALPRAZOLAM, COMPAZINE, LEXAPRO, PROBIOTICS. Patient recovered.Abraxane Side Effects Report #6105728-3
Abraxane side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2009. Female patient, weighting 121.3 lb, was diagnosed with neoplasm malignant and was treated with Abraxane. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pulmonary embolism
. Abraxane dosage: 410 MG D1/CYCLE 042. During the same period patient was treated with VANDETANIB, PANCRELIPASE, ATENOLOL, ALPRAZOLAM, COMPAZINE, LEXAPRO, PROBIOTICS. Patient recovered.Abraxane Side Effects Report #5878932-7
Abraxane side effect was reported by a Health Professional from JAPAN on Sept 02, 2008. Male patient, 61 years of age, was diagnosed with metastatic gastric cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased. Abraxane dosage: 260 MG/M2. During the same period patient was treated with LOXOPROFEN, OXINORM. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5976510-2
Abraxane side effect was reported by a Health Professional from CANADA on Nov 11, 2008. Male patient, 63 years of age, was diagnosed with head and neck cancer
and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood sodium decreased, catheter related complication, diarrhoea, febrile neutropenia, haemoglobin decreased, heart rate increased, hypokalaemia, thrombocytopenia, venous thrombosis limb. Abraxane dosage: 118 MG. During the same period patient was treated with CISPLATIN, FLUOROURACIL, ACETAMINOPHEN, MOUTHWASH. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #6026083-3
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 18, 2008. Male patient, 60 years of age, weighting 178.8 lb, was diagnosed with head and neck cancer
and was treated with Abraxane. After drug was administered, patient experienced the following side effects: aspiration, choking , dyspnoea, haematocrit decreased, haemoglobin decreased, tachycardia, vomiting. Abraxane dosage: (42 MG), INTRANEOUS. During the same period patient was treated with ERBITUX, CARBOPLATIN, ATIVAN, DECADRON, DIFLUCAN, FENTANYL, FLONASE, KBL SOLUTION. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #4777270-3
Abraxane side effect was reported by a Physician from UNITED STATES on Aug 30, 2005. Female patient, 68 years of age, weighting 123.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: aphasia
, arthralgia, blood culture positive, escherichia infection, haematocrit decreased, haemoglobin decreased, lethargy, listeriosis, neutropenia. Abraxane dosage: (400 MG, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with ACIPHEX, CELEBREX, HYDROCHLOROTHIAZIDE. Patient died on 08/23/2005.Abraxane Side Effects Report #5286078-4
Abraxane side effect was reported by a Health Professional from UNITED STATES on Mar 17, 2007. Female patient, 63 years of age, weighting 165.3 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anorexia, dysgeusia, facial palsy, haemoglobin decreased, neuropathy peripheral. Abraxane dosage: 440 MG DAY/EVERY 3 WEEKS/11 DOSES (440 MG, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PREVACID, POTASSIUM CHLORIDE, LEVOTHYROXINE, COZAAR. Patient died.
Abraxane Side Effects Report #5051512-1
Abraxane side effect was reported by a Health Professional from UNITED STATES on June 22, 2006. Female patient, 63 years of age, weighting 165.3 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anorexia, facial palsy, haemoglobin decreased, neuropathy peripheral. Abraxane dosage: 440 MG DAY/EVERY 3 WEEKS/11 DOSES (440 MG, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PREVACID, POTASSIUM CHLORIDE, LEVOTHYROXINE, COZAAR. Patient recovered.
Abraxane Side Effects Report #5034078-1
Abraxane side effect was reported by a Health Professional from UNITED STATES on June 01, 2006. Female patient, 63 years of age, weighting 165.3 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: facial palsy, haemoglobin decreased, neuropathy peripheral. Abraxane dosage: 440 MG DAY/EVERY 3 WEEKS/11 DOSES (440 MG, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PREVACID, POTASSIUM CHLORIDE, LEVOTHYROXINE, COZAAR. Patient recovered.
Abraxane Side Effects Report #5472250-7
Abraxane side effect was reported by a Pharmacist from UNITED STATES on Sept 11, 2007. Female patient, 59 years of age, weighting 198.4 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: dysuria, haemoglobin decreased, heart rate increased, hepatic failure, mental status changes, oedema peripheral, oesophageal varices haemorrhage, pain in extremity, platelet count abnormal. Abraxane dosage: 244 MG (125 MG/M2, WEEKLY - ONLY ONE DOSE GIVEN), INTRAVENOUS. During the same period patient was treated with ZOMETA, DARVOCET, PRILOSEC. Patient was hospitalized. Patient died on 08/24/2007.
Abraxane Side Effects Report #5227176-0
Abraxane side effect was reported by a Health Professional from UNITED STATES on Jan 17, 2007. Female patient, 61 years of age, weighting 175.2 lb, was diagnosed with breast cancer
and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, hypokalaemia, international normalised ratio increased, prothrombin time prolonged, white blood cell count decreased. Abraxane dosage: 338 MG/ CYCLE 5, DAY 20/ DATE OF LAST DOSE GIVEN 27NOV06 (175 MG/M2), INTRAVENOUS. During the same period patient was treated with EPIRUBICIN, GEMCITABINE, COUMADIN, DIOVAN, TOPROL. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #5272409-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Mar 02, 2007. Female patient, 53 years of age, weighting 137.0 lb, was diagnosed with breast cancer
, colony stimulating factor prophylaxis and was treated with Abraxane. After drug was administered, patient experienced the following side effects: abscess bacterial, abscess intestinal, bacteria stool identified, clostridial infection, enterocolitis infectious, escherichia infection, haemoglobin decreased, lung consolidation, pelvic abscess. Abraxane dosage: 292MG TOTAL DOSE / LAST DOSE PRIOR TO SAE 01-FEB-2007 (175 MG/M2), INTRAVENOUS. During the same period patient was treated with GEMCITABINE, EPIRUBICIN, NEULASTA, EMEND, COMPAZINE, DARVOCET, MIRALAX, DICYCLOMINE. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #5307797-7
Abraxane side effect was reported by a Health Professional from UNITED STATES on Apr 03, 2007. Female patient, 53 years of age, weighting 137.0 lb, was diagnosed with breast cancer
, colony stimulating factor prophylaxis and was treated with Abraxane. After drug was administered, patient experienced the following side effects: abscess intestinal, bacteria stool identified, candidiasis, enterocolitis infectious, haemoglobin decreased, large intestine perforation, lung consolidation, platelet count decreased, pleural effusion. Abraxane dosage: 292MG TOTAL DOSE/LAST DOSE PRIOR TO SAE 01-FEB-2007(175MG/M2); INTRAVENOUS. During the same period patient was treated with GEMCITABINE, EPIRUBICIN, NEULASTA, EMEND, COMPAZINE, DARVOCET, MIRALAX, DICYCLOMINE. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #5566843-6
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 12, 2007. Female patient, 50 years of age, weighting 348.3 lb, was diagnosed with breast cancer
and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, blood culture positive, chills, dyspnoea, groin abscess, haemoglobin decreased, lip ulceration, perineal abscess. Abraxane dosage: unknown. During the same period patient was treated with CARBOPLATIN, HERCEPTIN, AVASTIN, PROTONIX, WELLBUTRIN, ASPIRIN. Patient was hospitalized. Patient recovered.